SlideShare ist ein Scribd-Unternehmen logo
1 von 13
Health System Efficiency
             and Sustainability
        Jorge Mestre-Ferrandiz, Ruth Puig-Peiro,
           Priya Sharma, Jon Sussex, Yan Feng
                     OHE Consulting
This work was funded by Eli Lilly and Company. The views expressed here
               do not necessarily represent Lilly’s views.
                 Poster presentation
   9th HTAi Annual Meeting, Bilbao, 25-27 June 2012
Background
OHE Consulting was commissioned by Eli Lilly and Company’s
Global Public Policy department to identify and analyse
inefficiencies and bottlenecks that undermine health care system
sustainability and potential policy solutions.

Our main findings were presented as a poster at the 9th HTAi
Annual Meeting, Bilbao, 25-27 June 2012. We have reproduced
that poster here as a slide presentation.
Introduction
• Payers continually seek to increase and improve the
  outputs achieved by the health care system they
  fund
• Current economic climate: increased pressure to
  constrain costs and, with it, greater desire to
  increase health system efficiency
Objectives: Scope of Work
• Evidence and analysis of inefficiencies and
  bottlenecks
• Based on literature review and 2 rounds of
  interviews with expert commentators
• Potential policy solutions to tackle inefficiencies
• 7 target countries: Australia, Canada, France,
  Germany, Italy, Spain and the UK
Methods
•   Selective literature review
•   Interview programme with 15 independent
    academic commentators (29 interviews across 7
    countries in 2 rounds)
•   Identified a long list of inefficiencies (including
    ‘unsustainabilities’) in the 7 countries’ health care
    systems
Methods, cont’d
•   Identified a short list of five key inefficiencies to be
    explored further:
       •   Lack of primary/secondary care coordination
       •   Inappropriate use of resources because of
           no/insufficient cost benefit analysis (CBA) to assess
           how to spend health care budget
       •   Inappropriate use of resources because of weak or
           perverse financial incentives to providers
       •   Inconsistent implementation of HTA/guidance
       •   Chronic disease management (CDM)
Results
• Among the independent commentators, unanimous
  support for more chronic disease management
  •   With integrated care pathways, across primary and secondary care
      combined with financial incentives
  •   Including patient education and mutual support initiatives
  •   With appropriate regulation to require and monitor implementation
  •   Prospect of cost savings from fewer exacerbations and consequent
      hospital admissions as well as better care.

• Unanimous support for CBA/evaluation of health
  care pathways and preventive interventions
Result, cont’d.
      • Other frequently mentioned policies were:
             •   Electronic health records
             •   Information to patients to manage demand, improve
                 care coordination and support disease
                 management/self-care
             •   Clinical guidelines
      • Very little evidence exists on the magnitudes of any
        impacts of the different policies discussed to
        address the key inefficiencies

23/01/2013                                                           8
Conclusions
• The focus of health care policy thinking is now much
  more on:
  •   Removing perverse incentives
  •   Filling gaps in information to payers, health care
      professionals and patients
  •   More/better CDM and better coordination of
      care, especially between primary and secondary care
  •   Better compliance with good practice guidelines
Conclusions, cont’d.
• Much can be gained from further emphasis on
  chronic diseases management (CDM), even though
  the idea has been around quite a long time
  • Within CDM, the chronic care model (CCM) is one of the
    most common models discussed internationally. Overall,
    the evidence seems to suggest that CCM is cost-effective;
    while evidence on this is limited, information is starting to
    emerge
  • The 7 countries explored in this study all are active in CDM
    to some degree, albeit with significant differences across
    them.
Conclusions, cont’d
• A number of challenges were identified with
  implementing CDM initiatives
   •   Data collection and registries
   •   Lack of evaluation
   •   Engagement with health care professionals
   •   Support for patient self-management
   •   Incentives (financial and non-financial)

• The consensus is that more evaluation of CDM
  programmes is needed
Key References
OECD. (2009) Achieving better value for money in health care. Paris:
  Organisation for Economic Cooperation and Development.

Busse, R. et al. (2010) Tackling chronic disease in Europe: Strategies,
  interventions and challenges. Observatory studies series No. 20.
  Copenhagen: WHO Regional Office for Europe.

Nolte, E., McKee, M. and Knai, C. (2008) Managing chronic
  conditions: An introduction to the experience in eight countries.
  In Managing chronic conditions: Experience in eight countries.
  Copenhagen: WHO Regional Office for Europe. 1-14.
To enquire about additional information and analyses, please
contact Jorge Mestre-Ferrandiz at jmestre-ferrandiz@ohe.org

To keep up with the latest news and research, subscribe to our blog, OHE
News
Follow us on Twitter @OHENews, LinkedIn and SlideShare

Office of Health Economics (OHE)
Southside, 7th Floor
105 Victoria Street
London SW1E 6QT
United Kingdom
+44 20 7747 8850
www.ohe.org
OHE’s publications may be downloaded free of charge for registered users of its
website.

©2013 OHE

Weitere ähnliche Inhalte

Was ist angesagt?

Presentation on the literature review of interventions to improve health care...
Presentation on the literature review of interventions to improve health care...Presentation on the literature review of interventions to improve health care...
Presentation on the literature review of interventions to improve health care...IDS
 
Evidence on Improving Health Service Delivery in Developing Countries
Evidence on Improving Health Service Delivery in Developing CountriesEvidence on Improving Health Service Delivery in Developing Countries
Evidence on Improving Health Service Delivery in Developing CountriesIDS
 
Assessing the Return on Investment in Health IT: An Exploration of Costs and...
Assessing the Return on Investment in Health IT:  An Exploration of Costs and...Assessing the Return on Investment in Health IT:  An Exploration of Costs and...
Assessing the Return on Investment in Health IT: An Exploration of Costs and...Health Informatics New Zealand
 
Implementing The Chronic Disease Management Framework - Shared Care - M Goulb...
Implementing The Chronic Disease Management Framework - Shared Care - M Goulb...Implementing The Chronic Disease Management Framework - Shared Care - M Goulb...
Implementing The Chronic Disease Management Framework - Shared Care - M Goulb...Michelle Goulbourne @ DiaMind Health
 
Nhs england healthcare delivery model
Nhs england healthcare delivery modelNhs england healthcare delivery model
Nhs england healthcare delivery modelrylc
 
Analysis of cross-country changes in health services
Analysis of cross-country changes in health services Analysis of cross-country changes in health services
Analysis of cross-country changes in health services IDS
 
Pathways to scaling up health services Peters and Paina
Pathways to scaling up health services Peters and PainaPathways to scaling up health services Peters and Paina
Pathways to scaling up health services Peters and PainaIDS
 
EUPATI guidances for interaction between Patient organisations and other stak...
EUPATI guidances for interaction between Patient organisations and other stak...EUPATI guidances for interaction between Patient organisations and other stak...
EUPATI guidances for interaction between Patient organisations and other stak...EUPATI
 
Uncover Hidden Population Using Predictive Modeling Tool
Uncover Hidden Population Using Predictive Modeling Tool Uncover Hidden Population Using Predictive Modeling Tool
Uncover Hidden Population Using Predictive Modeling Tool VitreosHealth
 
Mental Health & HIV Integration - Melissa Sharer and Malia Duffy
Mental Health & HIV Integration - Melissa Sharer and Malia DuffyMental Health & HIV Integration - Melissa Sharer and Malia Duffy
Mental Health & HIV Integration - Melissa Sharer and Malia DuffyCORE Group
 
Availability, accessibility and applicability of evidence: Transferability - ...
Availability, accessibility and applicability of evidence: Transferability - ...Availability, accessibility and applicability of evidence: Transferability - ...
Availability, accessibility and applicability of evidence: Transferability - ...Office of Health Economics
 
Patient involvement prior to regulatory Scientific Advice
Patient involvement prior to regulatory Scientific AdvicePatient involvement prior to regulatory Scientific Advice
Patient involvement prior to regulatory Scientific AdviceEUPATI
 
WhereArePatientsinDecisionMaking
WhereArePatientsinDecisionMakingWhereArePatientsinDecisionMaking
WhereArePatientsinDecisionMakingSuzanne Parsons
 

Was ist angesagt? (20)

Presentation on the literature review of interventions to improve health care...
Presentation on the literature review of interventions to improve health care...Presentation on the literature review of interventions to improve health care...
Presentation on the literature review of interventions to improve health care...
 
Evidence on Improving Health Service Delivery in Developing Countries
Evidence on Improving Health Service Delivery in Developing CountriesEvidence on Improving Health Service Delivery in Developing Countries
Evidence on Improving Health Service Delivery in Developing Countries
 
Assessing the Return on Investment in Health IT: An Exploration of Costs and...
Assessing the Return on Investment in Health IT:  An Exploration of Costs and...Assessing the Return on Investment in Health IT:  An Exploration of Costs and...
Assessing the Return on Investment in Health IT: An Exploration of Costs and...
 
Implementing The Chronic Disease Management Framework - Shared Care - M Goulb...
Implementing The Chronic Disease Management Framework - Shared Care - M Goulb...Implementing The Chronic Disease Management Framework - Shared Care - M Goulb...
Implementing The Chronic Disease Management Framework - Shared Care - M Goulb...
 
Nhs england healthcare delivery model
Nhs england healthcare delivery modelNhs england healthcare delivery model
Nhs england healthcare delivery model
 
James Downie
James DownieJames Downie
James Downie
 
Analysis of cross-country changes in health services
Analysis of cross-country changes in health services Analysis of cross-country changes in health services
Analysis of cross-country changes in health services
 
Poster
PosterPoster
Poster
 
Pathways to scaling up health services Peters and Paina
Pathways to scaling up health services Peters and PainaPathways to scaling up health services Peters and Paina
Pathways to scaling up health services Peters and Paina
 
Improving Healthcare Systems Program
Improving Healthcare Systems ProgramImproving Healthcare Systems Program
Improving Healthcare Systems Program
 
EUPATI guidances for interaction between Patient organisations and other stak...
EUPATI guidances for interaction between Patient organisations and other stak...EUPATI guidances for interaction between Patient organisations and other stak...
EUPATI guidances for interaction between Patient organisations and other stak...
 
Towse ISPOR Incoming President's Remarks
Towse ISPOR Incoming President's RemarksTowse ISPOR Incoming President's Remarks
Towse ISPOR Incoming President's Remarks
 
Uncover Hidden Population Using Predictive Modeling Tool
Uncover Hidden Population Using Predictive Modeling Tool Uncover Hidden Population Using Predictive Modeling Tool
Uncover Hidden Population Using Predictive Modeling Tool
 
OHE MIP Poster - HATi Toyko, May 2016
OHE MIP Poster - HATi Toyko, May 2016OHE MIP Poster - HATi Toyko, May 2016
OHE MIP Poster - HATi Toyko, May 2016
 
The High 5 S initiative
The High 5 S initiativeThe High 5 S initiative
The High 5 S initiative
 
Mental Health & HIV Integration - Melissa Sharer and Malia Duffy
Mental Health & HIV Integration - Melissa Sharer and Malia DuffyMental Health & HIV Integration - Melissa Sharer and Malia Duffy
Mental Health & HIV Integration - Melissa Sharer and Malia Duffy
 
Dr Rachel David
Dr Rachel DavidDr Rachel David
Dr Rachel David
 
Availability, accessibility and applicability of evidence: Transferability - ...
Availability, accessibility and applicability of evidence: Transferability - ...Availability, accessibility and applicability of evidence: Transferability - ...
Availability, accessibility and applicability of evidence: Transferability - ...
 
Patient involvement prior to regulatory Scientific Advice
Patient involvement prior to regulatory Scientific AdvicePatient involvement prior to regulatory Scientific Advice
Patient involvement prior to regulatory Scientific Advice
 
WhereArePatientsinDecisionMaking
WhereArePatientsinDecisionMakingWhereArePatientsinDecisionMaking
WhereArePatientsinDecisionMaking
 

Ähnlich wie Health System Efficiency and Sustainability in Australia, Canada, France, Germany, Italy, Spain and the UK

Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldChanges in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldjangeissler
 
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIESOPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIESOffice of Health Economics
 
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIESOPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIESOffice of Health Economics
 
Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldChanges in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldjangeissler
 
OHE Lecturing for Professional Training at International Centre of Parliament...
OHE Lecturing for Professional Training at International Centre of Parliament...OHE Lecturing for Professional Training at International Centre of Parliament...
OHE Lecturing for Professional Training at International Centre of Parliament...Office of Health Economics
 
Transforming Urgent and Emergency Care: Safer, Better, Faster
Transforming Urgent and Emergency Care: Safer, Better, FasterTransforming Urgent and Emergency Care: Safer, Better, Faster
Transforming Urgent and Emergency Care: Safer, Better, Fastermckenln
 
Health policy and planning
Health policy and planning Health policy and planning
Health policy and planning Rizwan S A
 
Paying for performance to improve the delivery of health interventions in LMICs
Paying for performance to improve the delivery of health interventions in LMICsPaying for performance to improve the delivery of health interventions in LMICs
Paying for performance to improve the delivery of health interventions in LMICsReBUILD for Resilience
 
How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...Todd Berner MD
 
How to Define Effective and Efficient Real World Trials
How to Define Effective and Efficient Real World TrialsHow to Define Effective and Efficient Real World Trials
How to Define Effective and Efficient Real World TrialsTodd Berner MD
 
Evidence based medicine
Evidence based medicineEvidence based medicine
Evidence based medicineImran Javed
 
Investing in specialised services - the prioritisation framework, pop up uni,...
Investing in specialised services - the prioritisation framework, pop up uni,...Investing in specialised services - the prioritisation framework, pop up uni,...
Investing in specialised services - the prioritisation framework, pop up uni,...NHS England
 
critical pathway & health care reforms
critical pathway & health care reformscritical pathway & health care reforms
critical pathway & health care reformssangeetha antoe
 
110512 icp-business-case-amended-final
110512 icp-business-case-amended-final110512 icp-business-case-amended-final
110512 icp-business-case-amended-finaltemptingmoney
 
· Psychiatric Mental Health Nursing. Scope and Standards of Practi.docx
· Psychiatric Mental Health Nursing. Scope and Standards of Practi.docx· Psychiatric Mental Health Nursing. Scope and Standards of Practi.docx
· Psychiatric Mental Health Nursing. Scope and Standards of Practi.docxoswald1horne84988
 
Joint Working workshop
Joint Working workshopJoint Working workshop
Joint Working workshopPM Society
 

Ähnlich wie Health System Efficiency and Sustainability in Australia, Canada, France, Germany, Italy, Spain and the UK (20)

Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldChanges in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical world
 
Foro calidad OPIMEC Richard Smith
Foro calidad OPIMEC Richard SmithForo calidad OPIMEC Richard Smith
Foro calidad OPIMEC Richard Smith
 
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIESOPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
 
at-mod-3-info.pptx
at-mod-3-info.pptxat-mod-3-info.pptx
at-mod-3-info.pptx
 
D3-UNICEF.ppt
D3-UNICEF.pptD3-UNICEF.ppt
D3-UNICEF.ppt
 
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIESOPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
 
Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldChanges in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical world
 
OHE Lecturing for Professional Training at International Centre of Parliament...
OHE Lecturing for Professional Training at International Centre of Parliament...OHE Lecturing for Professional Training at International Centre of Parliament...
OHE Lecturing for Professional Training at International Centre of Parliament...
 
Transforming Urgent and Emergency Care: Safer, Better, Faster
Transforming Urgent and Emergency Care: Safer, Better, FasterTransforming Urgent and Emergency Care: Safer, Better, Faster
Transforming Urgent and Emergency Care: Safer, Better, Faster
 
Cadth 2015 e6 1 corner
Cadth 2015 e6 1 cornerCadth 2015 e6 1 corner
Cadth 2015 e6 1 corner
 
Health policy and planning
Health policy and planning Health policy and planning
Health policy and planning
 
Paying for performance to improve the delivery of health interventions in LMICs
Paying for performance to improve the delivery of health interventions in LMICsPaying for performance to improve the delivery of health interventions in LMICs
Paying for performance to improve the delivery of health interventions in LMICs
 
How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...
 
How to Define Effective and Efficient Real World Trials
How to Define Effective and Efficient Real World TrialsHow to Define Effective and Efficient Real World Trials
How to Define Effective and Efficient Real World Trials
 
Evidence based medicine
Evidence based medicineEvidence based medicine
Evidence based medicine
 
Investing in specialised services - the prioritisation framework, pop up uni,...
Investing in specialised services - the prioritisation framework, pop up uni,...Investing in specialised services - the prioritisation framework, pop up uni,...
Investing in specialised services - the prioritisation framework, pop up uni,...
 
critical pathway & health care reforms
critical pathway & health care reformscritical pathway & health care reforms
critical pathway & health care reforms
 
110512 icp-business-case-amended-final
110512 icp-business-case-amended-final110512 icp-business-case-amended-final
110512 icp-business-case-amended-final
 
· Psychiatric Mental Health Nursing. Scope and Standards of Practi.docx
· Psychiatric Mental Health Nursing. Scope and Standards of Practi.docx· Psychiatric Mental Health Nursing. Scope and Standards of Practi.docx
· Psychiatric Mental Health Nursing. Scope and Standards of Practi.docx
 
Joint Working workshop
Joint Working workshopJoint Working workshop
Joint Working workshop
 

Mehr von Office of Health Economics

OHE presents at G20 AMR-R&D meeting in Paris - Adrian Towse
OHE presents at G20 AMR-R&D meeting in Paris - Adrian TowseOHE presents at G20 AMR-R&D meeting in Paris - Adrian Towse
OHE presents at G20 AMR-R&D meeting in Paris - Adrian TowseOffice of Health Economics
 
Pricing in emerging markets: options to get value for money - Adrian Towse
Pricing in emerging markets: options to get value for money - Adrian TowsePricing in emerging markets: options to get value for money - Adrian Towse
Pricing in emerging markets: options to get value for money - Adrian TowseOffice of Health Economics
 
% GDP spending in UK, G5 countries and OECD upper middle income countries. W...
% GDP spending in UK, G5 countries and OECD upper middle income countries.  W...% GDP spending in UK, G5 countries and OECD upper middle income countries.  W...
% GDP spending in UK, G5 countries and OECD upper middle income countries. W...Office of Health Economics
 
The role of real world data and evidence in building a sustainable & efficien...
The role of real world data and evidence in building a sustainable & efficien...The role of real world data and evidence in building a sustainable & efficien...
The role of real world data and evidence in building a sustainable & efficien...Office of Health Economics
 
ISPOR Education Symposium- Go where the money is
ISPOR Education Symposium- Go where the money isISPOR Education Symposium- Go where the money is
ISPOR Education Symposium- Go where the money isOffice of Health Economics
 
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...Office of Health Economics
 
IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY?
 IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY? IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY?
IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY?Office of Health Economics
 
Understanding what aspects of health and quality of life are important to people
Understanding what aspects of health and quality of life are important to peopleUnderstanding what aspects of health and quality of life are important to people
Understanding what aspects of health and quality of life are important to peopleOffice of Health Economics
 
Novel approaches for valuing health at the end of life
Novel approaches for valuing health at the end of lifeNovel approaches for valuing health at the end of life
Novel approaches for valuing health at the end of lifeOffice of Health Economics
 
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...Office of Health Economics
 
HTA and payment mechanisms for new drugs to tackle AMR
HTA and payment mechanisms for new drugs to tackle AMRHTA and payment mechanisms for new drugs to tackle AMR
HTA and payment mechanisms for new drugs to tackle AMROffice of Health Economics
 
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...Office of Health Economics
 
Pay for Performance for Specialised Care in England
Pay for Performance for Specialised Care in EnglandPay for Performance for Specialised Care in England
Pay for Performance for Specialised Care in EnglandOffice of Health Economics
 
Real option value drugs: is it really an option?
Real option value drugs: is it really an option?Real option value drugs: is it really an option?
Real option value drugs: is it really an option?Office of Health Economics
 
MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...
MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...
MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...Office of Health Economics
 

Mehr von Office of Health Economics (20)

Annual lecture
Annual lecture Annual lecture
Annual lecture
 
Devlin ispor 2020 issues panel 20.05.20
Devlin ispor 2020 issues panel 20.05.20 Devlin ispor 2020 issues panel 20.05.20
Devlin ispor 2020 issues panel 20.05.20
 
Towse 2020 antimicrobials melbourne final
Towse 2020 antimicrobials melbourne finalTowse 2020 antimicrobials melbourne final
Towse 2020 antimicrobials melbourne final
 
Towse cgd price transparency seminar
Towse cgd price transparency seminarTowse cgd price transparency seminar
Towse cgd price transparency seminar
 
OHE presents at G20 AMR-R&D meeting in Paris - Adrian Towse
OHE presents at G20 AMR-R&D meeting in Paris - Adrian TowseOHE presents at G20 AMR-R&D meeting in Paris - Adrian Towse
OHE presents at G20 AMR-R&D meeting in Paris - Adrian Towse
 
Pricing in emerging markets: options to get value for money - Adrian Towse
Pricing in emerging markets: options to get value for money - Adrian TowsePricing in emerging markets: options to get value for money - Adrian Towse
Pricing in emerging markets: options to get value for money - Adrian Towse
 
% GDP spending in UK, G5 countries and OECD upper middle income countries. W...
% GDP spending in UK, G5 countries and OECD upper middle income countries.  W...% GDP spending in UK, G5 countries and OECD upper middle income countries.  W...
% GDP spending in UK, G5 countries and OECD upper middle income countries. W...
 
The role of real world data and evidence in building a sustainable & efficien...
The role of real world data and evidence in building a sustainable & efficien...The role of real world data and evidence in building a sustainable & efficien...
The role of real world data and evidence in building a sustainable & efficien...
 
ISPOR Education Symposium- Go where the money is
ISPOR Education Symposium- Go where the money isISPOR Education Symposium- Go where the money is
ISPOR Education Symposium- Go where the money is
 
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...
 
IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY?
 IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY? IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY?
IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY?
 
Ispor 2019 poster - Patricia Cubi-Molla
Ispor 2019 poster - Patricia Cubi-MollaIspor 2019 poster - Patricia Cubi-Molla
Ispor 2019 poster - Patricia Cubi-Molla
 
Understanding what aspects of health and quality of life are important to people
Understanding what aspects of health and quality of life are important to peopleUnderstanding what aspects of health and quality of life are important to people
Understanding what aspects of health and quality of life are important to people
 
Novel approaches for valuing health at the end of life
Novel approaches for valuing health at the end of lifeNovel approaches for valuing health at the end of life
Novel approaches for valuing health at the end of life
 
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...
 
HTA and payment mechanisms for new drugs to tackle AMR
HTA and payment mechanisms for new drugs to tackle AMRHTA and payment mechanisms for new drugs to tackle AMR
HTA and payment mechanisms for new drugs to tackle AMR
 
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...
 
Pay for Performance for Specialised Care in England
Pay for Performance for Specialised Care in EnglandPay for Performance for Specialised Care in England
Pay for Performance for Specialised Care in England
 
Real option value drugs: is it really an option?
Real option value drugs: is it really an option?Real option value drugs: is it really an option?
Real option value drugs: is it really an option?
 
MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...
MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...
MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...
 

Kürzlich hochgeladen

Russian Call Girls Gunjur Mugalur Road : 7001305949 High Profile Model Escort...
Russian Call Girls Gunjur Mugalur Road : 7001305949 High Profile Model Escort...Russian Call Girls Gunjur Mugalur Road : 7001305949 High Profile Model Escort...
Russian Call Girls Gunjur Mugalur Road : 7001305949 High Profile Model Escort...narwatsonia7
 
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service MumbaiLow Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbaisonalikaur4
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Air-Hostess Call Girls Madambakkam - Phone No 7001305949 For Ultimate Sexual ...
Air-Hostess Call Girls Madambakkam - Phone No 7001305949 For Ultimate Sexual ...Air-Hostess Call Girls Madambakkam - Phone No 7001305949 For Ultimate Sexual ...
Air-Hostess Call Girls Madambakkam - Phone No 7001305949 For Ultimate Sexual ...Ahmedabad Escorts
 
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...narwatsonia7
 
Call Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service NoidaCall Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service NoidaPooja Gupta
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Call Girls Viman Nagar 7001305949 All Area Service COD available Any Time
Call Girls Viman Nagar 7001305949 All Area Service COD available Any TimeCall Girls Viman Nagar 7001305949 All Area Service COD available Any Time
Call Girls Viman Nagar 7001305949 All Area Service COD available Any Timevijaych2041
 
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingArunagarwal328757
 
Hemostasis Physiology and Clinical correlations by Dr Faiza.pdf
Hemostasis Physiology and Clinical correlations by Dr Faiza.pdfHemostasis Physiology and Clinical correlations by Dr Faiza.pdf
Hemostasis Physiology and Clinical correlations by Dr Faiza.pdfMedicoseAcademics
 
Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...
Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...
Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...narwatsonia7
 
Housewife Call Girls Hsr Layout - Call 7001305949 Rs-3500 with A/C Room Cash ...
Housewife Call Girls Hsr Layout - Call 7001305949 Rs-3500 with A/C Room Cash ...Housewife Call Girls Hsr Layout - Call 7001305949 Rs-3500 with A/C Room Cash ...
Housewife Call Girls Hsr Layout - Call 7001305949 Rs-3500 with A/C Room Cash ...narwatsonia7
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort ServiceCollege Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort ServiceNehru place Escorts
 
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service MumbaiVIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbaisonalikaur4
 
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service JaipurHigh Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipurparulsinha
 

Kürzlich hochgeladen (20)

Russian Call Girls Gunjur Mugalur Road : 7001305949 High Profile Model Escort...
Russian Call Girls Gunjur Mugalur Road : 7001305949 High Profile Model Escort...Russian Call Girls Gunjur Mugalur Road : 7001305949 High Profile Model Escort...
Russian Call Girls Gunjur Mugalur Road : 7001305949 High Profile Model Escort...
 
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service MumbaiLow Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Air-Hostess Call Girls Madambakkam - Phone No 7001305949 For Ultimate Sexual ...
Air-Hostess Call Girls Madambakkam - Phone No 7001305949 For Ultimate Sexual ...Air-Hostess Call Girls Madambakkam - Phone No 7001305949 For Ultimate Sexual ...
Air-Hostess Call Girls Madambakkam - Phone No 7001305949 For Ultimate Sexual ...
 
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
 
Call Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service NoidaCall Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service Noida
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Call Girls Viman Nagar 7001305949 All Area Service COD available Any Time
Call Girls Viman Nagar 7001305949 All Area Service COD available Any TimeCall Girls Viman Nagar 7001305949 All Area Service COD available Any Time
Call Girls Viman Nagar 7001305949 All Area Service COD available Any Time
 
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, Pricing
 
Hemostasis Physiology and Clinical correlations by Dr Faiza.pdf
Hemostasis Physiology and Clinical correlations by Dr Faiza.pdfHemostasis Physiology and Clinical correlations by Dr Faiza.pdf
Hemostasis Physiology and Clinical correlations by Dr Faiza.pdf
 
Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...
Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...
Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...
 
Housewife Call Girls Hsr Layout - Call 7001305949 Rs-3500 with A/C Room Cash ...
Housewife Call Girls Hsr Layout - Call 7001305949 Rs-3500 with A/C Room Cash ...Housewife Call Girls Hsr Layout - Call 7001305949 Rs-3500 with A/C Room Cash ...
Housewife Call Girls Hsr Layout - Call 7001305949 Rs-3500 with A/C Room Cash ...
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort ServiceCollege Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
 
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service MumbaiVIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
 
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service JaipurHigh Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
 

Health System Efficiency and Sustainability in Australia, Canada, France, Germany, Italy, Spain and the UK

  • 1. Health System Efficiency and Sustainability Jorge Mestre-Ferrandiz, Ruth Puig-Peiro, Priya Sharma, Jon Sussex, Yan Feng OHE Consulting This work was funded by Eli Lilly and Company. The views expressed here do not necessarily represent Lilly’s views. Poster presentation 9th HTAi Annual Meeting, Bilbao, 25-27 June 2012
  • 2. Background OHE Consulting was commissioned by Eli Lilly and Company’s Global Public Policy department to identify and analyse inefficiencies and bottlenecks that undermine health care system sustainability and potential policy solutions. Our main findings were presented as a poster at the 9th HTAi Annual Meeting, Bilbao, 25-27 June 2012. We have reproduced that poster here as a slide presentation.
  • 3. Introduction • Payers continually seek to increase and improve the outputs achieved by the health care system they fund • Current economic climate: increased pressure to constrain costs and, with it, greater desire to increase health system efficiency
  • 4. Objectives: Scope of Work • Evidence and analysis of inefficiencies and bottlenecks • Based on literature review and 2 rounds of interviews with expert commentators • Potential policy solutions to tackle inefficiencies • 7 target countries: Australia, Canada, France, Germany, Italy, Spain and the UK
  • 5. Methods • Selective literature review • Interview programme with 15 independent academic commentators (29 interviews across 7 countries in 2 rounds) • Identified a long list of inefficiencies (including ‘unsustainabilities’) in the 7 countries’ health care systems
  • 6. Methods, cont’d • Identified a short list of five key inefficiencies to be explored further: • Lack of primary/secondary care coordination • Inappropriate use of resources because of no/insufficient cost benefit analysis (CBA) to assess how to spend health care budget • Inappropriate use of resources because of weak or perverse financial incentives to providers • Inconsistent implementation of HTA/guidance • Chronic disease management (CDM)
  • 7. Results • Among the independent commentators, unanimous support for more chronic disease management • With integrated care pathways, across primary and secondary care combined with financial incentives • Including patient education and mutual support initiatives • With appropriate regulation to require and monitor implementation • Prospect of cost savings from fewer exacerbations and consequent hospital admissions as well as better care. • Unanimous support for CBA/evaluation of health care pathways and preventive interventions
  • 8. Result, cont’d. • Other frequently mentioned policies were: • Electronic health records • Information to patients to manage demand, improve care coordination and support disease management/self-care • Clinical guidelines • Very little evidence exists on the magnitudes of any impacts of the different policies discussed to address the key inefficiencies 23/01/2013 8
  • 9. Conclusions • The focus of health care policy thinking is now much more on: • Removing perverse incentives • Filling gaps in information to payers, health care professionals and patients • More/better CDM and better coordination of care, especially between primary and secondary care • Better compliance with good practice guidelines
  • 10. Conclusions, cont’d. • Much can be gained from further emphasis on chronic diseases management (CDM), even though the idea has been around quite a long time • Within CDM, the chronic care model (CCM) is one of the most common models discussed internationally. Overall, the evidence seems to suggest that CCM is cost-effective; while evidence on this is limited, information is starting to emerge • The 7 countries explored in this study all are active in CDM to some degree, albeit with significant differences across them.
  • 11. Conclusions, cont’d • A number of challenges were identified with implementing CDM initiatives • Data collection and registries • Lack of evaluation • Engagement with health care professionals • Support for patient self-management • Incentives (financial and non-financial) • The consensus is that more evaluation of CDM programmes is needed
  • 12. Key References OECD. (2009) Achieving better value for money in health care. Paris: Organisation for Economic Cooperation and Development. Busse, R. et al. (2010) Tackling chronic disease in Europe: Strategies, interventions and challenges. Observatory studies series No. 20. Copenhagen: WHO Regional Office for Europe. Nolte, E., McKee, M. and Knai, C. (2008) Managing chronic conditions: An introduction to the experience in eight countries. In Managing chronic conditions: Experience in eight countries. Copenhagen: WHO Regional Office for Europe. 1-14.
  • 13. To enquire about additional information and analyses, please contact Jorge Mestre-Ferrandiz at jmestre-ferrandiz@ohe.org To keep up with the latest news and research, subscribe to our blog, OHE News Follow us on Twitter @OHENews, LinkedIn and SlideShare Office of Health Economics (OHE) Southside, 7th Floor 105 Victoria Street London SW1E 6QT United Kingdom +44 20 7747 8850 www.ohe.org OHE’s publications may be downloaded free of charge for registered users of its website. ©2013 OHE